Literature DB >> 28769081

Lifetime self-reported arthritis is associated with elevated levels of mental health burden: A multi-national cross sectional study across 46 low- and middle-income countries.

Brendon Stubbs1,2,3,4, Nicola Veronese5,6, Davy Vancampfort7,8, Trevor Thompson9, Cristiano Kohler10, Patricia Schofield11, Marco Solmi8,12, James Mugisha13,14, Kai G Kahl15, Toby Pillinger16,17, Andre F Carvalho18, Ai Koyanagi19,20.   

Abstract

Population-based studies investigating the relationship of arthritis with mental health outcomes are lacking, particularly among low- and middle-income countries (LMICs). We investigated the relationship between arthritis and mental health (depression spectrum, psychosis spectrum, anxiety, sleep disturbances and stress) across community-dwelling adults aged ≥18 years across 46 countries from the World Health Survey. Symptoms of psychosis and depression were established using questions from the Mental Health Composite International Diagnostic Interview. Severity of anxiety, sleep problems, and stress sensitivity over the preceding 30 days were self-reported. Self-report lifetime history of arthritis was collected, including presence or absence of symptoms suggestive of arthritis: pain, stiffness or swelling of joints over the preceding 12-months. Multivariable logistic regression analyses were undertaken. Overall, 245,706 individuals were included. Having arthritis increased the odds of subclinical psychosis (OR = 1.85; 95%CI = 1.72-1.99) and psychosis (OR = 2.48; 95%CI = 2.05-3.01). People with arthritis were at increased odds of subsyndromal depression (OR = 1.92; 95%CI = 1.64-2.26), a brief depressive episode (OR = 2.14; 95%CI = 1.88-2.43) or depressive episode (OR = 2.43; 95%CI = 2.21-2.67). Arthritis was also associated with increased odds for anxiety (OR = 1.75; 95%CI = 1.63-1.88), sleep problems (OR = 2.23; 95%CI = 2.05-2.43) and perceived stress (OR = 1.43; 95%CI = 1.33-1.53). Results were similar for middle-income and low-income countries. Integrated interventions addressing arthritis and mental health comorbidities are warranted to tackle this considerable burden.

Entities:  

Mesh:

Year:  2017        PMID: 28769081      PMCID: PMC5541038          DOI: 10.1038/s41598-017-07688-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

Recent global burden of disease surveys have demonstrated that chronic musculoskeletal and joint conditions are leading causes of disability, particularly in Western societies[1, 2]. One of the main clusters of chronic musculoskeletal and joint disorders is arthritis, a broad term encompassing osteoarthritis (OA) and inflammatory arthritic conditions such as rheumatoid arthritis (RA). The hallmark features of arthritis in both OA and RA are pain and discomfort. Unsurprisingly, an increasing body of evidence has demonstrated that OA[3] and RA[4] are associated with high levels of disability and lower quality of life[5]. Recently, there is increasing interest in the mental health burden of arthritis. Specifically, Matcham et al.[6] in a meta-analysis of 72 studies established that 38% of people with RA met the criteria for depression according to the Patient Health Questionnaire[7] whilst 16.8% had major depressive disorder, figures considerably higher than the general population. The presence of anxiety and depression in RA is important since it is known to predict treatment response in patients with RA[8]. Stubbs et al.[9] recently conducted a meta-analysis and established that one fifth of people with OA had anxiety or depression. A recent longitudinal study in North America demonstrated that multisite OA is associated with an increased incidence of depression[10]. A number of single country studies have also demonstrated that RA[11] and OA[12] are associated with sleep disturbance. Sleep disturbance and perceived stress have also been demonstrated to be associated with worse outcomes in people with RA[13]. Thus, clearly, mental health symptoms are common and negatively impact the quality of life and treatment outcomes for people with arthritis. Whilst progress has been made in understanding the mental health burden associated with arthritis, some pertinent limitations and gaps within the literature exist. First, to date, most studies considering arthritis and mental health have been based on clinical samples, and there is a lack of community-based studies. Moreover, there is a paucity of large representative multinational studies, particularly among low- and middle-income countries (LMICs). The majority of the world’s population resides in LMICs. A recent meta-analysis demonstrated that 3.16 million males and 14.87 million females were affected by RA in 2010 in LMICs with a rapid increase expected[14]. Resources to deal with the physical aspect of arthritis or mental health generally are not well established nor a priority in LMICs. Therefore, this comorbidity may be particularly challenging in this setting, and understanding the mental health burden of arthritis is important for planning service development. Moreover, people in LMICs are more likely to undertake labor-demanding jobs in the informal sector with no job security or compensation for lost income. Therefore, maintaining good mental and physical health is crucial for their livelihoods and general welfare. Furthermore, it is possible, for example, that pain associated with arthritis could increase the mental health burden and stress in an environment where reliance on income from labor-demanding jobs is widespread. Therefore, there is a need to elucidate the potential mental health burden among people with arthritis in LMICs. Second, the majority of studies considering mental health comorbidity and arthritis have focused on common mental disorders such as depression or anxiety and very few studies have considered psychosis for instance. However, there is an intriguing negative relationship that has been reported between schizophrenia and RA in Western counties[15] and a paucity of data is available on arthritis and people with psychotic symptoms who do not meet the criteria for a diagnosis. In addition, there is increasing recognition that depression sits on a continuum with various subtypes, yet there is a lack of studies considering the relationship between arthritis and the depression continuum. Clearly, understanding a wider range of mental health comorbidities (including depression subtypes, psychosis, sleep disturbance, anxiety, and perceived stress) in arthritis important. Given the aforementioned, the aim of the current study was to explore the relationship between arthritis and mental health (depression subtypes, psychosis, anxiety, sleep problems, and stress sensitivity). We hypothesized that people with arthritis in both low-income and middle-income countries would have worse mental health outcomes than those without arthritis.

Data and Methods

Procedures

The data for the current study was captured from the World Health Survey (WHS). The WHS was a cross-sectional study undertaken in 2002–2004 in 70 countries worldwide. Data were collected using single-stage random sampling and stratified multi-stage random cluster sampling across 10 and 60 countries respectively. Full details of the WHS are available elsewhere (http://www.who.int/healthinfo/survey/en/). In brief, persons aged ≥18 years with a valid home address were eligible to participate. Each member of the household had equal probability of being selected by utilizing Kish tables. A standardized questionnaire, translated accordingly was used across all countries. Linguists ensured that the translation was conducted to a high standard. The individual response rate (i.e. ratio of completed interviews among selected respondents after excluding ineligible respondents from the denominator) ranged from 63% (Israel) to 99% (Philippines)[16]. Ethical approval to conduct this study was obtained from the ethical boards at each study site (see Appendix 1 for details of approving board at each study site) and in accordance with each sites regulations. Sampling weights were generated to adjust for non-response and the population distribution reported by the United Nations Statistical Division. Informed consent was obtained from all participants. Of the 70 countries, 69 had data which were publically available. Of these, 10 countries (Austria, Belgium, Denmark, Germany, Greece, Guatemala, Italy, Netherlands, Slovenia, and UK) were excluded due to lack of data on sampling information. Furthermore, 10 high-income countries (Finland, France, Ireland, Israel, Luxembourg, Norway, Portugal, Spain, Sweden, United Arab Emirates) were excluded in order to focus on LMICs. Of the remaining LMICs, Slovakia, Congo, and Swaziland were excluded as >25% of the data on arthritis was missing. Thus, the final sample consisted of 46 countries which corresponded to 20 low-income and 26 middle-income countries according to the World Bank classification at the time of the survey (2003).

Primary variables

Arthritis (exposure variable)

Individuals with a self-reported lifetime diagnosis of arthritis and/or typical symptoms of arthritis were considered to have arthritis. The specific question used to assess a lifetime diagnosis was “Have you ever been diagnosed with arthritis (a disease of the joints)”? We also used a symptom-based approach to minimize reporting bias especially in areas where access to medical facilities is limited. The symptom-based algorithm was based on questions on typical clinical symptoms used in previous publications using the same questionnaire[17, 18]. Specifically, those who replied affirmatively to both of the following questions were considered to have arthritis: During the last 12 months, have you experienced: (a) pain, aching, stiffness or swelling in or around the joint (like arms, hands, legs or feet) which were not related to an injury and lasted for more than a month?; (b) stiffness in the joint in the morning after getting up from bed, or after a long rest of the joint without movement?

Mental health conditions (outcome variables)

Depression type

The severity of depressive symptoms was established based on the individual questions of the World Mental Health Survey version of the Mental Health Composite International Diagnostic Interview (CIDI), which assessed the duration and persistence of depressive symptoms in the past 12 months[19]. Following the algorithms used in a previous WHS publication[20], four mutually exclusive groups were established based on the ICD-10 Diagnostic Criteria for Research (ICD-10-DCR) where criterion B referred to symptoms of depressed mood, loss of interest, and fatigability. The algorithms used to define the four groups were the following: (a) Depressive episode group: At least two criterion B symptoms together with a total of at least four depressive symptoms lasting two weeks most of the day or all of the day. (b) Brief depressive episode group: Same criteria as depressive episode above but duration did not meet the two-week duration criterion. (c) Subsyndromal depression: At least one criterion B symptom together with the total number of symptoms being three or less. The criteria of duration of at least two weeks and presence of symptoms during most of the day had to be met. (d) No depressive disorder group: None of the above.

Psychosis

Participants were asked whether they had ever been diagnosed as having schizophrenia or psychosis. All participants, regardless of a psychosis diagnosis, were asked questions on positive psychotic symptoms which came from the WHO Composite International Diagnostic Interview(CIDI) 3.0[19]. This psychosis module has been reported to be highly consistent with clinician ratings with a kappa agreement coefficient of 0.82 for DSM-IV diagnosis of schizophrenia with even higher concordance observed for hallucinations and delusions[21]. Furthermore, psychotic experiences determined with the CIDI have been reported to be a good screening tool to identify those at high risk of developing psychosis[22]. The hallucinations question excluded conditions associated with sleep-related states or substance use. Specifically, respondents were asked the following questions with answer options ‘yes’ or ‘no’: During the last 12 months, have you experienced (i) ‘A feeling something strange and unexplainable was going on that other people would find hard to believe’? (delusional mood); (ii) ‘A feeling that people were too interested in you or there was a plot to harm you’? (delusions of reference and persecution); (iii) ‘A feeling that your thoughts were being directly interfered or controlled by another person, or your mind was being taken over by strange forces’? (delusions of control); (iv) ‘An experience of seeing visions or hearing voices that others could not see or hear when you were not half asleep, dreaming or under the influence of alcohol or drugs’? (hallucinations). Individuals who endorsed at least one of the four above-mentioned psychotic symptoms were considered to have psychotic symptoms. Based on information on psychosis diagnosis and psychotic symptoms, a three-category psychosis variable was constructed: (i) no psychosis diagnosis and no psychotic symptoms (control); (ii) at least one psychotic symptom but no psychosis diagnosis (subclinical psychosis); and (iii) psychosis diagnosis[23, 24].

Sleep problems

Sleep problems were assessed by the question “Overall in the last 30 days, how much of a problem did you have with sleeping, such as falling asleep, waking up frequently during the night or waking up too early in the morning”? with answer options none, mild, moderate, severe, and extreme. Those who answered severe and extreme were considered to have sleep problems. This definition has been used in previous publications using the same survey question on sleep problems[18, 25, 26].

Anxiety

Anxiety was assessed by the question “Overall in the past 30 days, how much of a problem did you have with worry or anxiety”? Respondents could answer: none, mild, moderate, severe, or extreme. In the current study those who answered severe and extreme were categorized as having anxiety[26, 27].

Perceived stress

Perceived stress in the last month was assessed by two questions: “How often have you felt that you were unable to control the important things in your life”?; and “How often have you found that you could not cope with all the things that you had to do?” The answer options to these questions were: never (score = 1), almost never (score = 2), sometimes (score = 3), fairly often (score = 4), very often (score = 5). The scores of the two questions were added to create a scale ranging from 2 to 10[28]. The highest quintile (cut-off ≥7) was used to define a high level of perceived stress.

Other variables

Variables on sex, age, highest education achieved (no formal education, primary education, secondary or high school completed, or tertiary education completed), wealth, setting (rural or urban), smoking, alcohol consumption, angina, asthma, diabetes, and Body Mass Index (BMI) were considered as potential correlates of arthritis based on past literature[4, 29]. Principal component analysis based on 15–20 assets was performed to establish country-wise wealth quintiles. The question on smoking was ‘Do you currently smoke any tobacco products such as cigarettes, cigars, or pipes’? with the answer options being ‘daily’, ‘yes, but not daily’, or ‘no, not at all’. This variable was dichotomized into those who smoked regardless of frequency (i.e. daily or not daily) (current smokers) and those who do not smoke. Alcohol consumption was assessed by first asking the question ‘Have you ever consumed a drink that contains alcohol (such as beer, wine, etc.)’? Respondents who replied ‘no’ were considered lifetime abstainers. If the respondent replied affirmatively, then he/she was asked how many standard drinks of any alcoholic beverage he/she had on each day of the past 7 days. The number of days in the past week in which 4 (female) or 5 (male) drinks were consumed was calculated, and a total of 1–2 and >3 days in the past 7 days were considered infrequent and frequent heavy drinking respectively. Those who have ever consumed alcohol but were neither an infrequent or frequent heavy drinker were considered to be non-heavy drinkers. A three-category variable was created: (a) lifetime abstainer or non-heavy drinker; (b) infrequent heavy drinker; and (c) frequent heavy drinker[30]. Asthma and diabetes were based solely on self-reported lifetime diagnosis. For angina, in addition to a self-reported diagnosis, a symptom-based diagnosis based on the Rose questionnaire was also used[31]. BMI was based on self-reported weight and height, and was calculated as weight in kilograms divided by height in meters squared. BMI was categorized as <18.5 (underweight), 18.5–24.9 (normal weight), 25.0–29.9 (overweight), and ≥30 (obese) kg/m2 [32].

Statistical analysis

The statistical analysis was performed with Stata 14.1 (Stata Corp LP, College station, Texas). The age- and sex-adjusted prevalence of arthritis for each country was estimated by using the United Nations population pyramids for the year 2010 (http://esa.un.org/wpp/Excel-Data/population.htm) as the standard population using age strata of 18–34, 35–59, and ≥60 years. The subsequent analyses used the overall sample including all countries or samples by country-income level (i.e. low-income or middle-income countries). Multivariable binary logistic regression analysis with arthritis as the outcome was performed to assess the correlates of arthritis. The correlates considered were sex, age, education, wealth, setting, smoking, alcohol consumption, angina, asthma, diabetes, and BMI. In order to assess the association between arthritis (exposure variable) and the mental health outcomes, multivariable binary and multinomial logistic regression analyses were conducted. Multinomial logistic regression analysis was conducted for psychosis and depression type, which consisted of more than two categories. When anxiety, sleep problems, and perceived stress were the outcome, binary logistic regression analysis was conducted. These analyses adjusted for all the potential correlates mentioned above as they have been reported to be associated with both arthritis and mental health outcomes[12, 33–37]. All variables were included in the models as categorical variables with the exception of age (continuous variable). All regression analyses were adjusted for country by including dummy variables for each country in the models, as in previous WHS publications[38, 39]. We did not use multilevel models as multilevel analyses with complex study designs can produce potentially biased estimates[40]. Turkey was not included in the regression analyses as it lacked data on education. Furthermore, due to completely missing data, the analysis with perceived stress as the outcome did not include Brazil, Hungary, and Zimbabwe, while Morocco was omitted from the analysis with anxiety as the outcome. The sample weighting and the complex study design were taken into account in all analyses with the use of the Stata svy command. Results from the logistic regression models are presented as odds ratios (ORs) with 95% confidence intervals (CIs). The level of statistical significance was set at P < 0.05. Less than 5% of the data was missing for all variables used in the analysis with the exception of education (8.1%), wealth (8.4%), alcohol consumption (5.2%), BMI (30.1%), diabetes (15.9%), and psychosis (15.8%). For the regression analyses, we conducted multiple imputation of missing values using the mi commands in Stata using chained equations (20 imputations)[41]. This method uses information from all other variables except the one being imputed to impute missing values. The variables included in the imputation model were the outcome and all other covariates[42]. A predictive mean matching algorithm was used for continuous variables, while for dichotomous and ordinal variables, binary logistic regression models and ordered logistic regression models, respectively, were used. The results based on complete case analysis were similar (Appendixs 2 and 3).

Results

A total of 245,706 individuals (LIC = 102,211 and MIC = 143,495) constituted the final analytical sample. Overall, there were more females than males (50.7% vs. 49.3%), and the mean (SD) age was 38.4 (16.0) years. The sample size of each country ranged from 929 (Latvia) to 38,746 (Mexico) (Table 1). The age- and sex-adjusted prevalence of arthritis in the overall sample was 22.4% (95%CI = 21.9%–22.8%) with the corresponding figures for low-income and middle-income countries being 23.4% (95%CI = 22.7%–24.1%) and 20.9 (95%CI = 20.4%–21.9%) respectively. This figure ranged from 7.2% (Myanmar) to 42.6% (Malawi) with high prevalence also being observed in Chad (40.6%), Morocco (34.7%), and India (32.4%) (Table 1, Fig. 1). The sample characteristics are shown in Table 2. In the overall sample, female sex, older age, lower education, poverty, rural setting, smoking, lower alcohol consumption, angina, asthma, diabetes, higher BMI, and all the mental health outcomes were more common among those with arthritis (Table 2).
Table 1

Sample size and age- and sex-adjusted prevalence of arthritis by country.

CountryLow-income countriesMiddle-income countries
Unweighted N% (SE)CountryUnweighted N% (SE)
Bangladesh5,94224.0 (1.1)Bosnia Herzegovina1,03118.8 (1.8)
Burkina Faso4,94820.2 (1.4)Brazil5,00020.6 (0.7)
Chad4,87040.6 (1.4)China3,99414.2 (1.1)
Comoros1,83618.5 (1.4)Croatia99322.8 (1.4)
Ethiopia5,08931.2 (1.2)Czech Republic94924.0 (1.9)
Ghana4,16519.0 (0.8)Dominican Republic5,02720.1 (0.8)
India10,68732.4 (1.3)Ecuador5,67516.9 (0.9)
Ivory Coast3,25121.5 (1.2)Estonia1,02027.4 (1.7)
Kenya4,64015.4 (0.9)Georgia2,95023.0 (0.9)
Laos4,98812.9 (0.7)Hungary1,41930.1 (1.2)
Malawi5,55142.6 (1.1)Kazakhstan4,49921.7 (0.8)
Mali4,88619.9 (0.9)Latvia92924.2 (1.7)
Mauritania3,90228.4 (1.2)Malaysia6,14514.2 (0.5)
Myanmar6,0457.2 (0.6)Mauritius3,96815.2 (0.9)
Nepal8,82030.1 (0.6)Mexico38,7469.7 (0.3)
Pakistan6,50119.7 (0.8)Morocco5,00034.7 (1.1)
Senegal3,46127.3 (1.2)Namibia4,37915.5 (1.0)
Vietnam4,1749.4 (0.9)Paraguay5,28818.5 (0.6)
Zambia4,1659.0 (0.7)Philippines10,08327.3 (0.8)
Zimbabwe4,29011.8 (0.7)Russia4,42722.5 (1.2)
South Africa2,62920.9 (1.3)
Sri Lanka6,80514.7 (0.8)
Tunisia5,20230.9 (0.9)
Turkey11,48119.1 (0.7)
Ukraine2,86025.1 (1.3)
Uruguay2,99614.1 (0.5)

Abbreviation: SE standard error.

All age- and sex-adjusted weighted estimates were calculated using the United Nations population pyramids for the year 2010.

Figure 1

Age- and sex-adjusted prevalence (%) of arthritis. Estimates were calculated using the United Nations population pyramids for the year 2010. The figure was created with STATA 13.1 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP).

Table 2

Sample characteristics (overall and by country-income level and the presence of arthritis).

CharacteristicCategoryOverallLow-income countriesMiddle-income countries
TotalArthritisTotalArthritisTotalArthritis
NoYesNoYesNoYes
49.351.939.050.552.941.447.750.635.8
Female50.748.161.049.547.158.652.349.464.2
Age (years)Mean38.435.948.136.834.645.140.537.651.8
(SD)(16.0)(14.8)(16.8)(15.3)(14.1)(16.8)(16.6)(15.4)(16.4)
Educationa No formal26.523.438.440.636.456.67.05.513.2
≤Primary30.930.930.832.934.028.728.126.833.7
Secondary completed33.436.023.420.522.811.551.254.239.7
Tertiary completed9.29.67.56.06.83.113.613.513.5
WealthPoorest20.119.323.520.219.623.020.119.024.2
Poorer20.119.422.720.019.222.820.119.622.5
Middle20.020.020.019.919.820.020.220.320.1
Richer19.820.417.620.020.518.019.720.317.3
Richest20.020.916.220.020.916.219.920.916.1
SettingRural55.754.659.574.873.880.631.030.532.7
Urban44.345.440.525.226.219.469.069.567.3
SmokingNo73.173.472.073.374.468.672.972.176.3
Yes26.926.628.026.725.631.427.127.923.7
AlcoholNever/non-heavy95.495.196.397.897.997.592.491.994.7
consumptionInfrequent heavy3.63.82.81.51.51.66.26.74.3
Frequent heavy1.01.00.90.70.70.81.41.51.0
AnginaNo85.790.566.885.289.767.586.391.465.9
Yes14.39.533.214.810.332.513.78.634.1
AsthmaNo94.995.991.195.997.091.893.794.690.2
Yes5.14.18.94.13.08.26.35.49.8
DiabetesNo97.097.993.798.198.695.895.596.890.8
Yes3.02.16.31.91.44.24.53.29.2
BMI (kg/m2)18.5–24.957.659.350.562.163.157.753.355.643.9
25.0–29.919.819.222.611.511.213.027.927.031.6
≥309.18.013.76.15.77.712.010.319.2
<18.513.513.513.220.320.021.66.87.15.4
PsychosisSymptom (−) Diagnosis (−)85.087.375.885.988.475.783.785.776.0
Symptom (+) Diagnosis (−)13.911.921.812.910.721.615.413.622.1
Diagnosis (+)1.10.82.31.20.92.70.90.61.9
Depression typeNo depression88.491.375.688.391.374.588.591.277.1
Subsyndromal depression2.41.94.83.02.36.21.61.32.8
Brief depressive episode2.72.25.02.31.94.23.42.76.1
Depressive episode6.54.614.66.44.515.16.64.813.9
Anxietyb No88.490.679.890.993.282.285.287.476.6
Yes11.69.420.29.16.817.814.812.623.4
Sleep problemsNo92.394.981.893.095.483.791.394.379.3
Yes7.75.118.27.04.616.38.75.720.7
Perceived stressc No80.583.070.976.078.566.488.991.479.3
Yes19.517.029.124.021.533.611.18.620.7

Abbreviation: SD standard deviation; BMI body mass index.

Data are % unless otherwise stated.

All estimates are based on weighted sample.

aTurkey is not included as it lacked information on education.

bMorocco is not included as it lacked information on anxiety.

cBrazil, Hungary, and Zimbabwe are not included as they lacked information on perceived stress.

Sample size and age- and sex-adjusted prevalence of arthritis by country. Abbreviation: SE standard error. All age- and sex-adjusted weighted estimates were calculated using the United Nations population pyramids for the year 2010. Age- and sex-adjusted prevalence (%) of arthritis. Estimates were calculated using the United Nations population pyramids for the year 2010. The figure was created with STATA 13.1 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP). Sample characteristics (overall and by country-income level and the presence of arthritis). Abbreviation: SD standard deviation; BMI body mass index. Data are % unless otherwise stated. All estimates are based on weighted sample. aTurkey is not included as it lacked information on education. bMorocco is not included as it lacked information on anxiety. cBrazil, Hungary, and Zimbabwe are not included as they lacked information on perceived stress. The correlates of arthritis estimated by multivariable binary logistic regression are presented in Table 3. In the overall sample, female sex, older age, lower education, poverty, smoking, angina, asthma, diabetes, and higher BMI were associated with arthritis. Similar correlates were found in the samples stratified by country-income level although there were some differences. Specifically, wealth and BMI were not significantly associated with arthritis in low-income countries.
Table 3

Correlates of arthritis assessed by multivariable binary logistic regression analysis.

CharacteristicOverallLow-income countriesMiddle-income countries
OR95%CIOR95%CIOR95%CI
Sex
 Male1.001.001.00
 Female1.58***[1.50,1.67]1.56***[1.45,1.69]1.62***[1.51,1.74]
Age (years)1.04***[1.04,1.04]1.04***[1.04,1.04]1.04***[1.04,1.05]
Education
 No formal1.001.001.00
 ≤Primary0.95[0.88,1.01]0.94[0.86,1.02]0.95[0.84,1.07]
 Secondary completed0.75***[0.69,0.82]0.71***[0.63,0.80]0.82**[0.72,0.94]
 Tertiary completed0.69***[0.62,0.78]0.62***[0.51,0.76]0.78**[0.66,0.92]
Wealth
 Poorest1.001.001.00
 Poorer1.04[0.97,1.13]1.08[0.97,1.20]0.98[0.88,1.08]
 Middle0.97[0.90,1.05]0.98[0.88,1.09]0.94[0.85,1.04]
 Richer0.90*[0.82,0.98]0.92[0.81,1.04]0.86**[0.76,0.96]
 Richest0.86**[0.78,0.95]0.88[0.76,1.01]0.84**[0.74,0.95]
Setting
 Rural1.001.001.00
 Urban0.94[0.87,1.01]0.93[0.82,1.05]0.95[0.87,1.04]
Smoking
 No1.001.001.00
 Yes1.16***[1.08,1.23]1.17**[1.07,1.29]1.16***[1.07,1.26]
Alcohol consumption
 Never/non-heavy1.001.001.00
 Infrequent heavy1.01[0.89,1.16]1.26[0.97,1.64]0.94[0.81,1.09]
 Frequent heavy0.96[0.77,1.20]1.17[0.88,1.55]0.82[0.59,1.15]
Angina 2.90***[2.71,3.10]2.86***[2.59,3.15]2.92***[2.69,3.17]
Asthma 1.49***[1.34,1.66]1.49***[1.28,1.75]1.50***[1.31,1.73]
Diabetes 1.58***[1.38,1.82]1.85***[1.45,2.36]1.39***[1.18,1.64]
BMI (kg/m2)
 18.5–24.91.001.001.00
 25.0–29.91.12**[1.05,1.21]1.06[0.95,1.19]1.21***[1.11,1.32]
 ≥30.01.34***[1.20,1.50]1.17[0.97,1.42]1.56***[1.39,1.74]
 <18.50.99[0.91,1.08]0.97[0.87,1.08]1.02[0.89,1.16]

Abbreviation: OR odds ratio; CI confidence interval; BMI Body mass index.

The models are adjusted for all variables in the table and country.

Turkey is not included in the regression analyses as it lacked information on education.

*p < 0.05, **p < 0.01, ***p < 0.001.

Correlates of arthritis assessed by multivariable binary logistic regression analysis. Abbreviation: OR odds ratio; CI confidence interval; BMI Body mass index. The models are adjusted for all variables in the table and country. Turkey is not included in the regression analyses as it lacked information on education. *p < 0.05, **p < 0.01, ***p < 0.001.

Mental health comorbidity and arthritis

The associations between arthritis and mental health outcomes estimated by multinomial and logistic regression are illustrated in Table 4. In the overall sample, after adjusting for potential confounders, having arthritis increased the odds of having subclinical psychosis (OR = 1.85; 95%CI = 1.72–1.99) or a psychosis diagnosis (OR = 2.48; 95%CI = 2.05–3.01) compared to no psychosis. The odds for all types of depression compared to no depression were also increased in those with arthritis: subsyndromal depression (OR = 1.92; 95%CI = 1.64–2.26); brief depressive episode (OR = 2.14; 95%CI = 1.88–2.43); depressive episode (OR = 2.43; 95%CI = 2.21–2.67). Furthermore, arthritis was also associated with increased odds for anxiety (OR = 1.75; 95%CI = 1.63–1.88); sleep problems (OR = 2.23; 95%CI = 2.05–2.43) and perceived stress (OR = 1.43; 95%CI = 1.33–1.53). The results for middle-income and low-income countries were similar.
Table 4

The association between arthritis and mental health outcomes estimated by multinomial and binary logistic regression.

OutcomeOverallLow-income countriesMiddle-income countries
OR95%CIOR95%CIOR95%CI
Multinomial logistic regression
Psychosis
  Symptom (−) Diagnosis (−)1.001.001.00
  Symptom (+) Diagnosis (−)1.85***[1.72,1.99]1.77***[1.59,1.97]1.98***[1.79,2.18]
  Diagnosis (+)2.48***[2.05,3.01]2.27***[1.77,2.91]2.98***[2.24,3.97]
Depression type
  No depression1.001.001.00
  Subsyndromal depression1.92***[1.64,2.26]1.89***[1.55,2.30]2.06***[1.59,2.67]
  Brief depressive episode2.14***[1.88,2.43]2.09***[1.75,2.49]2.23***[1.86,2.68]
  Depressive episode2.43***[2.21,2.67]2.39***[2.10,2.73]2.51***[2.21,2.83]
Binary logistic regression
  Anxietya 1.75***[1.63,1.88]1.69***[1.53,1.86]1.84***[1.65,2.05]
  Sleep problems2.23***[2.05,2.43]2.25***[1.99,2.55]2.21***[1.98,2.47]
  Perceived stressb 1.43***[1.33,1.53]1.40***[1.28,1.52]1.49***[1.35,1.65]

Abbreviation: OR odds ratio; CI confidence interval.

All models are adjusted for sex, age, education, wealth, setting, smoking, alcohol consumption, angina, asthma, diabetes, BMI, and country.

Turkey is not included in the regression analyses as it lacked information on education.

aMorocco is not included as it lacked information on anxiety.

bBrazil, Hungary, and Zimbabwe are not included as they lacked information on perceived stress.

***p < 0.001.

The association between arthritis and mental health outcomes estimated by multinomial and binary logistic regression. Abbreviation: OR odds ratio; CI confidence interval. All models are adjusted for sex, age, education, wealth, setting, smoking, alcohol consumption, angina, asthma, diabetes, BMI, and country. Turkey is not included in the regression analyses as it lacked information on education. aMorocco is not included as it lacked information on anxiety. bBrazil, Hungary, and Zimbabwe are not included as they lacked information on perceived stress. ***p < 0.001.

Discussion

The current large scale study involving almost a quarter of a million people over 46 LMICs established that the age- and sex-adjusted prevalence of arthritis was 22.4% across all countries and 23.4% in low-income and 20.9% in middle-income countries. In the overall sample, the correlates of arthritis estimated by multivariable logistic regression included female sex, older age, lower education, poverty, smoking, angina, asthma, diabetes, and higher BMI. In LMICs collectively, we observed that people with arthritis were consistently more likely to have depression (all subtypes), subclinical psychosis, established psychotic disorder, sleep problems, anxiety, and higher levels of perceived stress. The increased mental health comorbidity among those with arthritis was consistently raised in those in both low-income and middle-income countries. The prevalence of arthritis (22.3%) found in our LMIC sample was higher than a previous meta-analysis on the prevalence of RA which reported that 0.16% (95%CI: 0.11–0.20%) and 0.75% (95%CI: 0.60–0.90%) of males and females respectively had RA[14]. Moreover, this is also higher than the prevalence of OA reported in a recent global burden of disease survey of 3% and 5% in males and females respectively in Africa and central Asia[29]. However, a previous study using similar definitions of arthritis as in our study have found similarly high figures in 9 LMICs, although the sample was limited to adults aged 50 years or older[18]. The potential reason for this might be the self-report questions used in the WHS in addition to a reflection in a potentially heightened prevalence of pain and stiffness among the sample. In accordance with the literature in high-income countries[6, 8–10], we observed heightened odds for all depression subtypes among those with arthritis versus controls. In many ways, the heightened mental health comorbidity among those with arthritis is unsurprising given the potential impact of pain, disability, and pressure to continue earning to provide an income for the family. It is interesting to note that all depression subtypes were associated with heightened odds with arthritis and to the best of our knowledge, our paper is the first multinational paper to consider this relationship. This in contrast to recent work among people with back pain in LMICs, where an incremental increased odds of depression was noted with more severe depression subtypes[43]. It is also perhaps of little surprise that people with arthritis were more likely to have anxiety, sleep disturbances, and perceived stress. These relationships may potentially be explained by increased levels of pain associated with arthritis. Specifically, the underlying shared pathophysiology of pain and depression could account for this, since both depression and pain facilitate modulation in the periaqueductal gray, amygdala, and hypothalamus regions[44, 45]. Second, arthritis[46], pain, and depression[47] are associated with and exacerbated by low levels of physical activity and social isolation[48, 49]. Thus, it is possible that these factors, which were not assessed in the current study, are implicated in the link between arthritis and worse mental health. Increasing physical activity has established efficacy in reducing both depression[50, 51] and pain as well as their associated disability[52] and could therefore be key to reducing the burden of this comorbidity and improving function. Finally, within the context of some LMICs, the high prevalence of HIV and tuberculosis[53] may account for both the depression[54] and pain associated with arthritis[55]. The increased odds of arthritis among people with a diagnosis of psychosis has to the best of our knowledge not been previously reported in LMICs, and data on the relation between subclinical psychosis and arthritis is scarce. Furthermore, very few community-based multinational studies exist on these associations even in high-income countries. Our finding that arthritis is associated with higher odds for psychotic disorders (e.g. schizophrenia) is in contrast to the trend that has previously been reported. A recent meta-analysis with polygenic risk score analysis found that people with schizophrenia are at reduced odds of RA, although this does not appear to be related to polygenic risk scores and may be more related to environmental risk factors such as the anti-inflammatory effects of antipsychotic medication[56]. A nationally representative study in Taiwan found that people with schizophrenia were not more likely than controls to develop OA (HR = 0.89; 95%CI = 0.81–1.01), p = 0.53)[57]. Thus, it appears that people with psychosis in LMICs may be more likely to have arthritis compared to their high-income counterparts. The precise reasons for this are unclear and future studies are warranted to assess whether our results may be replicated. RA aside, there is evidence that any history of autoimmune disease (including psoriasis, which can have a significant joint component) can increase the odds of developing schizophrenia[58]. In terms of the heightened odds for subclinical psychosis in arthritis, this may be explained by the psychological distress caused by the symptoms of arthritis (e.g. pain) which has been associated with psychotic symptoms in the general population[30, 59, 60]. It is established from studies conducted in high-income countries that comorbid mental health outcomes among those with arthritis are associated with worse pain and poorer treatment outcomes[8, 10, 61]. Thus clearly integrated mental and physical healthcare is essential. However, in the context of arthritis, there is a paucity of evidence-based literature, in particular intervention studies. Regardless, the current data have important public health implications, particularly since the data were multi-national, population-based, and predominantly nationally representative, rather than most literature to date which is derived from clinical samples. Understanding and treating comorbid mental health outcomes among those with arthritis is essential. An important environmental barrier in the care of people with mental and physical health problems in LMICs is the lack of integrated mental and physical healthcare services and the poorly developed community-based psychiatric services[62]. Closer integration of primary and mental health care in these countries is needed, but without obscuring the responsibility for arthritis and mental health assessment, prevention and management[63]. We suggest that people with arthritis are assessed for the mental health conditions assessed in our study (i.e., depression, anxiety, sleep disturbance, stress and psychosis) so that appropriate interventions can be provided. More research is required to understand the mental health burden of arthritis in LMICs and context-specific trials and evaluations in LMICs therefore are urgently needed. Some study design limitations need to be considered. First, the categorization of arthritis was based on self-report and it was not possible to explore in more detail the type, nature, and severity of arthritis. In particular, it was not possible to differentiate between OA and RA and other forms of arthritis. Thus, clearly, future research is required to disentangle the nature and mental health impact of the different forms of arthritis in LMICs. Second, the study sample only included non-institutionalized individuals. Thus, those with severe mental disorders or arthritis could have been omitted from the sample, leading to an underestimate of the associations. Next, we adjusted for a variety of potential confounders but we cannot preclude the possibility of residual confounding. For example, we were only able to adjust for a limited number of physical comorbidities. Finally, the data is cross-sectional thus it is not possible to disentangle the directionality of the relationships observed. It is important that future research attempts to understand the underlying explanatory factors of the relationships we observed. In particular, research considering psychotic disorders and RA are required among LMICs. In conclusion, our large community-based study has demonstrated that arthritis is associated with a broad range of elevated mental health comorbidity. For the first time we demonstrated on a multinational scale that depression subtypes, psychosis spectrum, stress sensitivity and anxiety are increased in those with arthritis. Future longitudinal research is required to elucidate the course, trajectory, and outcomes of comorbid mental health and arthritis in LMICs. Appendix
  60 in total

1.  The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study.

Authors:  Marita Cross; Emma Smith; Damian Hoy; Sandra Nolte; Ilana Ackerman; Marlene Fransen; Lisa Bridgett; Sean Williams; Francis Guillemin; Catherine L Hill; Laura L Laslett; Graeme Jones; Flavia Cicuttini; Richard Osborne; Theo Vos; Rachelle Buchbinder; Anthony Woolf; Lyn March
Journal:  Ann Rheum Dis       Date:  2014-02-19       Impact factor: 19.103

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 3.  Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs.

Authors:  Eva Jané-Llopis; Irina Matytsina
Journal:  Drug Alcohol Rev       Date:  2006-11

4.  The association between psychosis and severe pain in community-dwelling adults: Findings from 44 low- and middle-income countries.

Authors:  Ai Koyanagi; Andrew Stickley
Journal:  J Psychiatr Res       Date:  2015-07-18       Impact factor: 4.791

5.  The epidemiology of back pain and its relationship with depression, psychosis, anxiety, sleep disturbances, and stress sensitivity: Data from 43 low- and middle-income countries.

Authors:  Brendon Stubbs; Ai Koyanagi; Trevor Thompson; Nicola Veronese; Andre F Carvalho; Marco Solomi; James Mugisha; Patricia Schofield; Theodore Cosco; Nicky Wilson; Davy Vancampfort
Journal:  Gen Hosp Psychiatry       Date:  2016-09-30       Impact factor: 3.238

6.  Chronic conditions and sleep problems among adults aged 50 years or over in nine countries: a multi-country study.

Authors:  Ai Koyanagi; Noe Garin; Beatriz Olaya; Jose Luis Ayuso-Mateos; Somnath Chatterji; Matilde Leonardi; Seppo Koskinen; Beata Tobiasz-Adamczyk; Josep Maria Haro
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

7.  The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses.

Authors:  Jack Euesden; Gerome Breen; Anne Farmer; Peter McGuffin; Cathryn M Lewis
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-02-05       Impact factor: 3.568

8.  Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trial.

Authors:  Faith Matcham; Sam Norton; David L Scott; Sophia Steer; Matthew Hotopf
Journal:  Rheumatology (Oxford)       Date:  2015-09-08       Impact factor: 7.580

9.  Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.

Authors:  Christopher J L Murray; Ryan M Barber; Kyle J Foreman; Ayse Abbasoglu Ozgoren; Foad Abd-Allah; Semaw F Abera; Victor Aboyans; Jerry P Abraham; Ibrahim Abubakar; Laith J Abu-Raddad; Niveen M Abu-Rmeileh; Tom Achoki; Ilana N Ackerman; Zanfina Ademi; Arsène K Adou; José C Adsuar; Ashkan Afshin; Emilie E Agardh; Sayed Saidul Alam; Deena Alasfoor; Mohammed I Albittar; Miguel A Alegretti; Zewdie A Alemu; Rafael Alfonso-Cristancho; Samia Alhabib; Raghib Ali; François Alla; Peter Allebeck; Mohammad A Almazroa; Ubai Alsharif; Elena Alvarez; Nelson Alvis-Guzman; Azmeraw T Amare; Emmanuel A Ameh; Heresh Amini; Walid Ammar; H Ross Anderson; Benjamin O Anderson; Carl Abelardo T Antonio; Palwasha Anwari; Johan Arnlöv; Valentina S Arsic Arsenijevic; Al Artaman; Rana J Asghar; Reza Assadi; Lydia S Atkins; Marco A Avila; Baffour Awuah; Victoria F Bachman; Alaa Badawi; Maria C Bahit; Kalpana Balakrishnan; Amitava Banerjee; Suzanne L Barker-Collo; Simon Barquera; Lars Barregard; Lope H Barrero; Arindam Basu; Sanjay Basu; Mohammed O Basulaiman; Justin Beardsley; Neeraj Bedi; Ettore Beghi; Tolesa Bekele; Michelle L Bell; Corina Benjet; Derrick A Bennett; Isabela M Bensenor; Habib Benzian; Eduardo Bernabé; Amelia Bertozzi-Villa; Tariku J Beyene; Neeraj Bhala; Ashish Bhalla; Zulfiqar A Bhutta; Kelly Bienhoff; Boris Bikbov; Stan Biryukov; Jed D Blore; Christopher D Blosser; Fiona M Blyth; Megan A Bohensky; Ian W Bolliger; Berrak Bora Başara; Natan M Bornstein; Dipan Bose; Soufiane Boufous; Rupert R A Bourne; Lindsay N Boyers; Michael Brainin; Carol E Brayne; Alexandra Brazinova; Nicholas J K Breitborde; Hermann Brenner; Adam D Briggs; Peter M Brooks; Jonathan C Brown; Traolach S Brugha; Rachelle Buchbinder; Geoffrey C Buckle; Christine M Budke; Anne Bulchis; Andrew G Bulloch; Ismael R Campos-Nonato; Hélène Carabin; Jonathan R Carapetis; Rosario Cárdenas; David O Carpenter; Valeria Caso; Carlos A Castañeda-Orjuela; Ruben E Castro; Ferrán Catalá-López; Fiorella Cavalleri; Alanur Çavlin; Vineet K Chadha; Jung-Chen Chang; Fiona J Charlson; Honglei Chen; Wanqing Chen; Peggy P Chiang; Odgerel Chimed-Ochir; Rajiv Chowdhury; Hanne Christensen; Costas A Christophi; Massimo Cirillo; Matthew M Coates; Luc E Coffeng; Megan S Coggeshall; Valentina Colistro; Samantha M Colquhoun; Graham S Cooke; Cyrus Cooper; Leslie T Cooper; Luis M Coppola; Monica Cortinovis; Michael H Criqui; John A Crump; Lucia Cuevas-Nasu; Hadi Danawi; Lalit Dandona; Rakhi Dandona; Emily Dansereau; Paul I Dargan; Gail Davey; Adrian Davis; Dragos V Davitoiu; Anand Dayama; Diego De Leo; Louisa Degenhardt; Borja Del Pozo-Cruz; Robert P Dellavalle; Kebede Deribe; Sarah Derrett; Don C Des Jarlais; Muluken Dessalegn; Samath D Dharmaratne; Mukesh K Dherani; Cesar Diaz-Torné; Daniel Dicker; Eric L Ding; Klara Dokova; E Ray Dorsey; Tim R Driscoll; Leilei Duan; Herbert C Duber; Beth E Ebel; Karen M Edmond; Yousef M Elshrek; Matthias Endres; Sergey P Ermakov; Holly E Erskine; Babak Eshrati; Alireza Esteghamati; Kara Estep; Emerito Jose A Faraon; Farshad Farzadfar; Derek F Fay; Valery L Feigin; David T Felson; Seyed-Mohammad Fereshtehnejad; Jefferson G Fernandes; Alize J Ferrari; Christina Fitzmaurice; Abraham D Flaxman; Thomas D Fleming; Nataliya Foigt; Mohammad H Forouzanfar; F Gerry R Fowkes; Urbano Fra Paleo; Richard C Franklin; Thomas Fürst; Belinda Gabbe; Lynne Gaffikin; Fortuné G Gankpé; Johanna M Geleijnse; Bradford D Gessner; Peter Gething; Katherine B Gibney; Maurice Giroud; Giorgia Giussani; Hector Gomez Dantes; Philimon Gona; Diego González-Medina; Richard A Gosselin; Carolyn C Gotay; Atsushi Goto; Hebe N Gouda; Nicholas Graetz; Harish C Gugnani; Rahul Gupta; Rajeev Gupta; Reyna A Gutiérrez; Juanita Haagsma; Nima Hafezi-Nejad; Holly Hagan; Yara A Halasa; Randah R Hamadeh; Hannah Hamavid; Mouhanad Hammami; Jamie Hancock; Graeme J Hankey; Gillian M Hansen; Yuantao Hao; Hilda L Harb; Josep Maria Haro; Rasmus Havmoeller; Simon I Hay; Roderick J Hay; Ileana B Heredia-Pi; Kyle R Heuton; Pouria Heydarpour; Hideki Higashi; Martha Hijar; Hans W Hoek; Howard J Hoffman; H Dean Hosgood; Mazeda Hossain; Peter J Hotez; Damian G Hoy; Mohamed Hsairi; Guoqing Hu; Cheng Huang; John J Huang; Abdullatif Husseini; Chantal Huynh; Marissa L Iannarone; Kim M Iburg; Kaire Innos; Manami Inoue; Farhad Islami; Kathryn H Jacobsen; Deborah L Jarvis; Simerjot K Jassal; Sun Ha Jee; Panniyammakal Jeemon; Paul N Jensen; Vivekanand Jha; Guohong Jiang; Ying Jiang; Jost B Jonas; Knud Juel; Haidong Kan; André Karch; Corine K Karema; Chante Karimkhani; Ganesan Karthikeyan; Nicholas J Kassebaum; Anil Kaul; Norito Kawakami; Konstantin Kazanjan; Andrew H Kemp; Andre P Kengne; Andre Keren; Yousef S Khader; Shams Eldin A Khalifa; Ejaz A Khan; Gulfaraz Khan; Young-Ho Khang; Christian Kieling; Daniel Kim; Sungroul Kim; Yunjin Kim; Yohannes Kinfu; Jonas M Kinge; Miia Kivipelto; Luke D Knibbs; Ann Kristin Knudsen; Yoshihiro Kokubo; Soewarta Kosen; Sanjay Krishnaswami; Barthelemy Kuate Defo; Burcu Kucuk Bicer; Ernst J Kuipers; Chanda Kulkarni; Veena S Kulkarni; G Anil Kumar; Hmwe H Kyu; Taavi Lai; Ratilal Lalloo; Tea Lallukka; Hilton Lam; Qing Lan; Van C Lansingh; Anders Larsson; Alicia E B Lawrynowicz; Janet L Leasher; James Leigh; Ricky Leung; Carly E Levitz; Bin Li; Yichong Li; Yongmei Li; Stephen S Lim; Maggie Lind; Steven E Lipshultz; Shiwei Liu; Yang Liu; Belinda K Lloyd; Katherine T Lofgren; Giancarlo Logroscino; Katharine J Looker; Joannie Lortet-Tieulent; Paulo A Lotufo; Rafael Lozano; Robyn M Lucas; Raimundas Lunevicius; Ronan A Lyons; Stefan Ma; Michael F Macintyre; Mark T Mackay; Marek Majdan; Reza Malekzadeh; Wagner Marcenes; David J Margolis; Christopher Margono; Melvin B Marzan; Joseph R Masci; Mohammad T Mashal; Richard Matzopoulos; Bongani M Mayosi; Tasara T Mazorodze; Neil W Mcgill; John J Mcgrath; Martin Mckee; Abigail Mclain; Peter A Meaney; Catalina Medina; Man Mohan Mehndiratta; Wubegzier Mekonnen; Yohannes A Melaku; Michele Meltzer; Ziad A Memish; George A Mensah; Atte Meretoja; Francis A Mhimbira; Renata Micha; Ted R Miller; Edward J Mills; Philip B Mitchell; Charles N Mock; Norlinah Mohamed Ibrahim; Karzan A Mohammad; Ali H Mokdad; Glen L D Mola; Lorenzo Monasta; Julio C Montañez Hernandez; Marcella Montico; Thomas J Montine; Meghan D Mooney; Ami R Moore; Maziar Moradi-Lakeh; Andrew E Moran; Rintaro Mori; Joanna Moschandreas; Wilkister N Moturi; Madeline L Moyer; Dariush Mozaffarian; William T Msemburi; Ulrich O Mueller; Mitsuru Mukaigawara; Erin C Mullany; Michele E Murdoch; Joseph Murray; Kinnari S Murthy; Mohsen Naghavi; Aliya Naheed; Kovin S Naidoo; Luigi Naldi; Devina Nand; Vinay Nangia; K M Venkat Narayan; Chakib Nejjari; Sudan P Neupane; Charles R Newton; Marie Ng; Frida N Ngalesoni; Grant Nguyen; Muhammad I Nisar; Sandra Nolte; Ole F Norheim; Rosana E Norman; Bo Norrving; Luke Nyakarahuka; In-Hwan Oh; Takayoshi Ohkubo; Summer L Ohno; Bolajoko O Olusanya; John Nelson Opio; Katrina Ortblad; Alberto Ortiz; Amanda W Pain; Jeyaraj D Pandian; Carlo Irwin A Panelo; Christina Papachristou; Eun-Kee Park; Jae-Hyun Park; Scott B Patten; George C Patton; Vinod K Paul; Boris I Pavlin; Neil Pearce; David M Pereira; Rogelio Perez-Padilla; Fernando Perez-Ruiz; Norberto Perico; Aslam Pervaiz; Konrad Pesudovs; Carrie B Peterson; Max Petzold; Michael R Phillips; Bryan K Phillips; David E Phillips; Frédéric B Piel; Dietrich Plass; Dan Poenaru; Suzanne Polinder; Daniel Pope; Svetlana Popova; Richie G Poulton; Farshad Pourmalek; Dorairaj Prabhakaran; Noela M Prasad; Rachel L Pullan; Dima M Qato; D Alex Quistberg; Anwar Rafay; Kazem Rahimi; Sajjad U Rahman; Murugesan Raju; Saleem M Rana; Homie Razavi; K Srinath Reddy; Amany Refaat; Giuseppe Remuzzi; Serge Resnikoff; Antonio L Ribeiro; Lee Richardson; Jan Hendrik Richardus; D Allen Roberts; David Rojas-Rueda; Luca Ronfani; Gregory A Roth; Dietrich Rothenbacher; David H Rothstein; Jane T Rowley; Nobhojit Roy; George M Ruhago; Mohammad Y Saeedi; Sukanta Saha; Mohammad Ali Sahraian; Uchechukwu K A Sampson; Juan R Sanabria; Logan Sandar; Itamar S Santos; Maheswar Satpathy; Monika Sawhney; Peter Scarborough; Ione J Schneider; Ben Schöttker; Austin E Schumacher; David C Schwebel; James G Scott; Soraya Seedat; Sadaf G Sepanlou; Peter T Serina; Edson E Servan-Mori; Katya A Shackelford; Amira Shaheen; Saeid Shahraz; Teresa Shamah Levy; Siyi Shangguan; Jun She; Sara Sheikhbahaei; Peilin Shi; Kenji Shibuya; Yukito Shinohara; Rahman Shiri; Kawkab Shishani; Ivy Shiue; Mark G Shrime; Inga D Sigfusdottir; Donald H Silberberg; Edgar P Simard; Shireen Sindi; Abhishek Singh; Jasvinder A Singh; Lavanya Singh; Vegard Skirbekk; Erica Leigh Slepak; Karen Sliwa; Samir Soneji; Kjetil Søreide; Sergey Soshnikov; Luciano A Sposato; Chandrashekhar T Sreeramareddy; Jeffrey D Stanaway; Vasiliki Stathopoulou; Dan J Stein; Murray B Stein; Caitlyn Steiner; Timothy J Steiner; Antony Stevens; Andrea Stewart; Lars J Stovner; Konstantinos Stroumpoulis; Bruno F Sunguya; Soumya Swaminathan; Mamta Swaroop; Bryan L Sykes; Karen M Tabb; Ken Takahashi; Nikhil Tandon; David Tanne; Marcel Tanner; Mohammad Tavakkoli; Hugh R Taylor; Braden J Te Ao; Fabrizio Tediosi; Awoke M Temesgen; Tara Templin; Margreet Ten Have; Eric Y Tenkorang; Abdullah S Terkawi; Blake Thomson; Andrew L Thorne-Lyman; Amanda G Thrift; George D Thurston; Taavi Tillmann; Marcello Tonelli; Fotis Topouzis; Hideaki Toyoshima; Jefferson Traebert; Bach X Tran; Matias Trillini; Thomas Truelsen; Miltiadis Tsilimbaris; Emin M Tuzcu; Uche S Uchendu; Kingsley N Ukwaja; Eduardo A Undurraga; Selen B Uzun; Wim H Van Brakel; Steven Van De Vijver; Coen H van Gool; Jim Van Os; Tommi J Vasankari; N Venketasubramanian; Francesco S Violante; Vasiliy V Vlassov; Stein Emil Vollset; Gregory R Wagner; Joseph Wagner; Stephen G Waller; Xia Wan; Haidong Wang; Jianli Wang; Linhong Wang; Tati S Warouw; Scott Weichenthal; Elisabete Weiderpass; Robert G Weintraub; Wang Wenzhi; Andrea Werdecker; Ronny Westerman; Harvey A Whiteford; James D Wilkinson; Thomas N Williams; Charles D Wolfe; Timothy M Wolock; Anthony D Woolf; Sarah Wulf; Brittany Wurtz; Gelin Xu; Lijing L Yan; Yuichiro Yano; Pengpeng Ye; Gökalp K Yentür; Paul Yip; Naohiro Yonemoto; Seok-Jun Yoon; Mustafa Z Younis; Chuanhua Yu; Maysaa E Zaki; Yong Zhao; Yingfeng Zheng; David Zonies; Xiaonong Zou; Joshua A Salomon; Alan D Lopez; Theo Vos
Journal:  Lancet       Date:  2015-08-28       Impact factor: 79.321

10.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Theo Vos; Abraham D Flaxman; Mohsen Naghavi; Rafael Lozano; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Richard Gosselin; Rebecca Grainger; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jixiang Ma; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  4 in total

1.  Patterns of Association between Depressive Symptoms and Chronic Medical Morbidities in Older Adults.

Authors:  Bruno Agustini; Mojtaba Lotfaliany; Robyn L Woods; John J McNeil; Mark R Nelson; Raj C Shah; Anne M Murray; Michael E Ernst; Christopher M Reid; Andrew Tonkin; Jessica E Lockery; Lana J Williams; Michael Berk; Mohammadreza Mohebbi
Journal:  J Am Geriatr Soc       Date:  2020-05-13       Impact factor: 5.562

2.  Ilizarov external fixation versus plate internal fixation in the treatment of end-stage ankle arthritis: decision analysis of clinical parameters.

Authors:  Jun Li; Bohua Li; Zhengdong Zhang; Shanxi Wang; Lei Liu
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

Review 3.  Qigong Exercise and Arthritis.

Authors:  Ray Marks
Journal:  Medicines (Basel)       Date:  2017-09-27

4.  Depressive symptoms and the risk of arthritis: A survival analysis using data from the osteoarthritis initiative.

Authors:  Vishal Vennu; Harsh Misra; Asha Misra
Journal:  Indian J Psychiatry       Date:  2019 Sep-Oct       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.